Form 4: Becton Dickinson Director Byington Reports Acquisition of Rights to Common Stock

Sentiment:

SEC Form 4 Filing


Director Carrie L Byington reports acquiring rights to 129 shares of Becton Dickinson common stock under the deferred compensation plan.

Summary

  • On May 3, 2024, Carrie L Byington, a director of Becton Dickinson & Co (BDX), acquired rights to 129 shares of common stock under the company's deferred compensation plan.
  • The price per share is $233.44.
  • These securities convert to common stock on a one-for-one basis and are distributed following termination of the director's service or on a specified date.
  • Following the transaction, Byington beneficially owns 1,162 rights to common stock, including rights acquired through dividend reinvestment.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a routine transaction. It doesn't indicate positive or negative sentiment.

Future Outlook

The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

Industry Context

This filing is a routine disclosure related to insider transactions and deferred compensation plans, common in publicly traded companies. It provides transparency into the holdings of company directors.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it involves a director's participation in a deferred compensation plan.

Key Dates

DateDescription
05/03/2024Date of transaction: Acquisition of rights to common stock under BD Deferred Compensation Plan
05/06/2024Date of signature on the report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.